Naxalgan (Pregabalin)

Pregabalin binds to the α2‑δ subunit of voltage‑gated calcium channels in the central nervous system, reducing calcium influx and consequently decreasing the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P, which helps control pain, seizures, and anxiety.

The specific dose of Naxalgan is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, renal function, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Pregabalin’s safety in pregnancy and lactation has not been fully established. Healthcare providers should weigh the potential benefits against possible risks and discuss these considerations with the patient before prescribing Naxalgan to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other gabapentinoids such as gabapentin, pregabalin (Naxalgan) generally offers more predictable pharmacokinetics, higher bioavailability, and a quicker onset of action, which can translate into more consistent pain relief for many patients.

Naxalgan should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Naxalgan is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include angioedema, severe hypersensitivity reactions, suicidal thoughts or behaviors, and rare hematologic abnormalities. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash, mood changes, or unexplained bruising.

Naxalgan is contraindicated in patients with known hypersensitivity to pregabalin or any of its excipients. Caution is also advised for individuals with severe renal impairment, uncontrolled heart failure, or a history of substance misuse, and it should be avoided in such cases unless a specialist determines the benefits outweigh the risks.